Biopharmaceutical Analysis & Statistics, January 2015 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

61-90 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Taiwan, Japan
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada
Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Brazil
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, South Africa
Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, Israel
ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, South Africa
SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Singapore
XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical, Livestock
  • Countries : South Korea
DiaMedica Inc. (Symbol:DMA) SWOT Analysis, Strategy, Revenues and Profits

DiaMedica Inc. (Symbol:DMA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Kamada Ltd. (Symbol:KMDA) SWOT Analysis, Strategy, Revenues and Profits

Kamada Ltd. (Symbol:KMDA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary iBio, Inc. (iBio) is a biotechnology company. The company develops and offers pharmaceutical product applications. It offers products such as vaccines, and biotherapeutics. iBio offers vaccines ...

  • Industries : Biopharmaceutical
  • Countries : United States
Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : China
Solco Biomedical Co., Ltd. (Symbol:043100) SWOT Analysis, Strategy, Revenues and Profits

Solco Biomedical Co., Ltd. (Symbol:043100) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Intellect Neurosciences, Inc. (Intellect Neuro) is a biopharmaceutical company. The company discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and ...

  • Industries : Biopharmaceutical
  • Countries : United States
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States
Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Gene Techno Science Co., Ltd. (GTS) is a biotechnology company. The company develops and markets drug and antibodies for intractable diseases and rare diseases. Its products include GND-001, GND-002, ...

  • Industries : Biopharmaceutical
Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Synageva BioPharma Corp. (Synageva) is a biopharmaceutical company. The company discovers, develops and delivers medicines for patients with rare disease and unmet medical needs. Its products include ...

  • Industries : Biopharmaceutical
  • Countries : United States

21 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.